X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-28 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $139.81 | -6,092 | 169,400 | -3% | -$851,712 | ||||||
| M | 2025-07-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $138.36 | -5,064 | 65,430 | -7% | -$700,670 | |||||
2025-07-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $139.81 | -479 | 316,886 | 0% | -$66,968 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $139.81 | -1,718 | 2,390,852 | 0% | -$240,191 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $139.81 | -2,206 | 126,059 | -2% | -$308,417 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $139.81 | -1,710 | 151,750 | -1% | -$239,072 | ||||||
2025-07-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $139.81 | -1,994 | 202,164 | -1% | -$278,778 | ||||||
2025-07-28 | ADT | Adt Inc. | Apollo Management Holdings Gp, LLC | 10% | S - Sale | $8.31 | -71,000,000 | 112,650,366 | -39% | -$590,010,000 | ||||||
2025-07-28 | ADT | Adt Inc. | Apollo Management Holdings Gp, LLC | 10% | S - Sale | $8.31 | -71,000,000 | 112,650,366 | -39% | -$590,010,000 | ||||||
| M | 2025-07-28 | TRAK | Repositrak, Inc. | Fields Randall K | CEO, 10% | S - Sale | $17.68 | -7,500 | 5,331,779 | 0% | -$132,636 | |||||
2025-07-29 | HSCS | Heartsciences Inc. | Hilz Mark T | COO, Secretary, Dir | S - Sale | $3.54 | -4,416 | 4,793 | -48% | -$15,621 | ||||||
2025-07-28 | NVTS | Navitas Semiconductor Corp | Singh Ranbir | Dir | S - Sale | $8.79 | -18,645,603 | 19,214,053 | -49% | -$163,894,850 | ||||||
2025-07-28 | NVTS | Navitas Semiconductor Corp | Singh Ranbir | Dir | P - Purchase | $8.79 | +18,645,603 | 19,214,053 | >999% | +$163,894,850 | ||||||
2025-07-28 | TEM | Tempus Ai, Inc. | Lefkofsky Eric P | CEO, COB, 10% | S - Sale | $62.87 | -166,250 | 39,779,745 | 0% | -$10,452,027 | ||||||
2025-07-30 | ACEL | Accel Entertainment, Inc. | Rubenstein Andrew H. | CEO, Pres, 10% | S - Sale | $13.08 | -15,000 | 3,967,934 | 0% | -$196,146 | ||||||
| D | 2025-07-30 | TDY | Teledyne Technologies Inc | Bobb George C III | Pres, CEO | S - Sale+OE | $555.41 | -6,735 | 10,391 | -39% | -$3,740,659 | |||||
| M | 2025-07-28 | MLYS | Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO, Secretary | S - Sale | $14.62 | -73,678 | 132,934 | -36% | -$1,077,477 | |||||
2025-07-28 | ZIP | Ziprecruiter, Inc. | Miller J Sanford | 10% | S - Sale | $4.64 | -5,811 | 8,418,717 | 0% | -$26,963 | ||||||
2025-07-28 | ANET | Arista Networks, Inc. | Ullal Jayshree | CEO, Chairperson | S - Sale | $115.59 | -527,302 | 35,907,341 | -1% | -$60,949,419 | ||||||
2025-07-29 | TEAM | Atlassian Corp | Cannon-Brookes Michael | CEO, Co-Founder, 10% | S - Sale | $200.20 | -7,665 | 337,260 | -2% | -$1,534,552 | ||||||
2025-07-29 | TEAM | Atlassian Corp | Farquhar Scott | Dir, 10% | S - Sale | $200.20 | -7,665 | 337,260 | -2% | -$1,534,552 | ||||||
2025-07-30 | TLRY | Tilray Brands, Inc. | Simon Irwin D | Pres, CEO | P - Purchase | $0.61 | +165,000 | 3,941,633 | +4% | +$100,106 | ||||||
| D | 2025-07-30 | NRIX | Nurix Therapeutics, Inc. | Van Houte Hans | CFO | S - Sale+OE | $12.01 | -4,304 | 40,914 | -10% | -$51,695 | |||||
| D | 2025-07-30 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | GC | S - Sale+OE | $12.01 | -3,841 | 44,009 | -8% | -$46,134 | |||||
| D | 2025-07-30 | NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | S - Sale+OE | $12.01 | -4,308 | 69,023 | -6% | -$51,743 | |||||
2025-07-30 | AGX | Argan Inc | Flanders Cynthia | Dir | S - Sale | $234.56 | -2,000 | 31,428 | -6% | -$469,120 | ||||||
2025-07-28 | FNWB | First Northwest Bancorp | Henderson Kyle David | EVP, Chief Credit Officer | P - Purchase | $7.74 | +3,000 | 16,271 | +23% | +$23,210 | ||||||
2025-07-29 | CVNA | Carvana Co. | Garcia Ernest C. III | CEO, 10% | S - Sale | $334.98 | -5,766 | 2,227,264 | 0% | -$1,931,474 | ||||||
| M | 2025-07-28 | CVNA | Carvana Co. | Garcia Ernest C. III | CEO, 10% | S - Sale | $334.22 | -14,234 | 2,233,030 | -1% | -$4,757,331 | |||||
2025-07-28 | IBKR | Interactive Brokers Group, Inc. | Nemser Earl H | Vice COB | S - Sale | $65.90 | -100 | 827,712 | 0% | -$6,590 | ||||||
| M | 2025-07-28 | ADAP | Adaptimmune Therapeutics Plc | Ecor1 Capital, LLC | 10% | S - Sale | $0.11 | -64,052,538 | 100,371,882 | -39% | -$6,890,236 | |||||
2025-07-29 | MBWM | Mercantile Bank Corp | Williams Shoran R | Dir | P - Purchase | $47.29 | +200 | 5,266 | +4% | +$9,457 | ||||||
2025-07-28 | ASAN | Asana, Inc. | Rosenstein Justin | Dir | S - Sale | $15.04 | -517,635 | 3,210,398 | -14% | -$7,783,936 | ||||||
2025-07-28 | META | Meta Platforms, Inc. | Olivan Javier | COO | S - Sale | $715.00 | -517 | 116,521 | 0% | -$369,655 | ||||||
| D | 2025-07-28 | ELVN | Enliven Therapeutics, Inc. | Hohl Benjamin | CFO | S - Sale+OE | $20.46 | -3,250 | 23,000 | -12% | -$66,504 | |||||
| DM | 2025-07-28 | R | Ryder System Inc | Sanchez Robert E | Chair, CEO | S - Sale+OE | $181.54 | -44,126 | 522,681 | -8% | -$8,010,527 | |||||
| M | 2025-07-28 | TLYS | Tilly'S, Inc. | Shay Capital LLC | 10% | P - Purchase | $1.95 | +100,000 | 3,300,000 | +3% | +$195,488 | |||||
| M | 2025-07-28 | GTX | Garrett Motion Inc. | Cyrus Capital Partners, L.P. | 10% | S - Sale | $13.09 | -175,695 | 22,671,300 | -1% | -$2,300,348 | |||||
| D | 2025-07-29 | R | Ryder System Inc | Gallo-Aquino Cristina | EVP, CFO | S - Sale+OE | $180.87 | -1,000 | 27,991 | -3% | -$180,870 | |||||
| M | 2025-07-28 | CELH | Celsius Holdings, Inc. | Milmoe William H. | 10% | S - Sale | $47.50 | -200,000 | 17,817,770 | -1% | -$9,500,000 | |||||
| M | 2025-07-28 | CELH | Celsius Holdings, Inc. | Desantis Deborah | 10% | S - Sale | $47.50 | -200,000 | 17,817,770 | -1% | -$9,500,000 | |||||
| M | 2025-07-28 | CELH | Celsius Holdings, Inc. | Desantis Dean | 10% | S - Sale | $47.50 | -200,000 | 17,817,770 | -1% | -$9,500,000 | |||||
2025-07-30 | OVLY | Oak Valley Bancorp | Holder H Randolph Jr | Dir | P - Purchase | $27.00 | +500 | 152,676 | 0% | +$13,500 | ||||||
| D | 2025-07-28 | TSCO | Tractor Supply Co /De/ | Yankee Colin | EVP Chief Supply Chain Officer | S - Sale+OE | $58.40 | -6,680 | 40,142 | -14% | -$390,121 | |||||
| DM | 2025-07-29 | LEXX | Lexaria Bioscience Corp. | Bunka Christopher | Dir | P - Purchase | $0.92 | +27,500 | 909,867 | +3% | +$25,241 | |||||
2025-07-29 | GSHD | Goosehead Insurance, Inc. | Jones Mark E. Jr. | CFO, 10% | P - Purchase | $86.08 | +1,149 | 3,491 | +49% | +$98,906 | ||||||
2025-07-30 | GAM | General American Investors Co Inc | Stark Eugene S | VP Administration, CCO, PFO | P - Purchase | $56.92 | +177 | 135,637 | 0% | +$10,075 | ||||||
| D | 2025-07-29 | CRM | Salesforce, Inc. | Benioff Marc | Chair, CEO | S - Sale+OE | $269.34 | -2,250 | 22,018,571 | 0% | -$606,014 | |||||
| M | 2025-07-28 | SHIM | Shimmick Corp | Goldsteen Mitchell B. | Dir, 10% | S - Sale | $1.88 | -8,958 | 21,247,925 | 0% | -$16,831 | |||||
2025-07-28 | BRZE | Braze, Inc. | Malik Astha | Chief Business Officer | S - Sale | $30.01 | -9,001 | 249,979 | -3% | -$270,120 | ||||||
2025-07-29 | CNTA | Centessa Pharmaceuticals Plc | Accardi Mario Alberto | Pres, Orexin Program | S - Sale | $15.23 | -8,322 | 208,163 | -4% | -$126,751 | ||||||
| D | 2025-07-28 | SEI | Solaris Energy Infrastructure, Inc. | J Turbines, Inc. | 10% | S - Sale+OE | $30.30 | -4,000,000 | 2,114,783 | -65% | -$121,200,000 | |||||
2025-07-29 | KPTI | Karyopharm Therapeutics Inc. | Poulton Stuart | EVP, Chief Development Officer | S - Sale | $4.37 | -191 | 27,223 | -1% | -$835 | ||||||
2025-07-30 | SERV | Serve Robotics Inc. /De/ | Read Brian | CFO | S - Sale | $10.46 | -1,212 | 396,266 | 0% | -$12,674 | ||||||
| M | 2025-07-28 | RLAY | Relay Therapeutics, Inc. | Rahmer Peter | See remarks | S - Sale | $3.68 | -17,083 | 377,998 | -4% | -$62,947 | |||||
| M | 2025-07-28 | RLAY | Relay Therapeutics, Inc. | Catinazzo Thomas | CFO | S - Sale | $3.69 | -20,081 | 335,295 | -6% | -$74,000 | |||||
| M | 2025-07-28 | RLAY | Relay Therapeutics, Inc. | Bergstrom Donald A | Pres, R, D | S - Sale | $3.69 | -30,770 | 552,720 | -5% | -$113,478 | |||||
| M | 2025-07-28 | RLAY | Relay Therapeutics, Inc. | Adams Brian | GC | S - Sale | $3.68 | -19,913 | 371,472 | -5% | -$73,378 | |||||
| D | 2025-07-25 | IMA | Imagenebio, Inc. | Bonita David P | Dir | P - Purchase | $29.90 | +83,611 | 774,133 | +12% | +$2,499,969 | |||||
2025-07-28 | SMCI | Super Micro Computer, Inc. | Liu Liang Chiu-Chu Sara | Dir, 10% | S - Sale | $60.00 | -200,000 | 66,706,324 | 0% | -$12,000,000 | ||||||
2025-07-30 | CARE | Carter Bankshares, Inc. | Midkiff Catharine L. | Dir | S - Sale | $17.76 | -2,000 | 17,254 | -10% | -$35,520 | ||||||
2025-07-11 | UPXI | Upexi, Inc. | Salkind Gene | Dir, 10% | P - Purchase | $4.94 | +20,243 | 585,370 | +4% | +$100,000 | ||||||
| D | 2025-07-25 | IMA | Imagenebio, Inc. | Stampacchia Otello | Dir | P - Purchase | $29.90 | +267,556 | 455,361 | +142% | +$7,999,924 | |||||
2025-07-28 | SMCI | Super Micro Computer, Inc. | Liang Charles | Pres, CEO, 10% | S - Sale | $60.00 | -200,000 | 66,706,324 | 0% | -$12,000,000 | ||||||
2025-07-28 | CRDO | Credo Technology Group Holding Ltd | Cheng Chi Fung | CTO | S - Sale | $105.80 | -55,000 | 7,280,851 | -1% | -$5,819,158 | ||||||
2025-07-30 | SSB | Southstate Corp | Froetscher Janet P | Dir | P - Purchase | $97.31 | +3,338 | 8,294 | +67% | +$324,821 | ||||||
2025-07-29 | GPI | Group 1 Automotive Inc | Mizell Steven | Dir | S - Sale | $417.98 | -525 | 8 | -98% | -$219,440 | ||||||
2025-07-30 | EPD | Enterprise Products Partners L.P. | Montgomery William C | Dir | P - Purchase | $31.55 | +16,000 | 136,920 | +13% | +$504,864 | ||||||
| M | 2025-07-28 | BFZ | Blackrock California Municipal Income Trust | Saba Capital Management, L.P. | 10% | S - Sale | $10.40 | -79,072 | 4,239,487 | -2% | -$822,034 | |||||
2025-07-29 | NVCR | Novocure Ltd | Brackmann Christoph | CFO | P - Purchase | $11.59 | +20,000 | 141,150 | +17% | +$231,800 | ||||||
2025-07-29 | WTFC | Wintrust Financial Corp | Dykstra David A | VICE COB, COO | S - Sale | $131.53 | -14,942 | 182,208 | -8% | -$1,965,321 | ||||||
2025-07-28 | LQDA | Liquidia Corp | Adair Jason | Chief Business Officer | S - Sale | $19.54 | -454 | 193,180 | 0% | -$8,871 | ||||||
2025-07-29 | TCBX | Third Coast Bancshares, Inc. | Glander Troy Andrew | Dir | S - Sale | $37.86 | -3,000 | 30,539 | -9% | -$113,594 | ||||||
| D | 2025-07-28 | CADL | Candel Therapeutics, Inc. | Nichols William Garrett | Chief Medical Officer | S - Sale+OE | $6.98 | -937 | 52,493 | -2% | -$6,540 | |||||
2025-07-28 | LQDA | Liquidia Corp | Boyle Dana | Chief Accounting Officer | S - Sale | $19.54 | -1,063 | 186,105 | -1% | -$20,771 | ||||||
2025-07-29 | TCBX | Third Coast Bancshares, Inc. | Bobbora William | See Remarks | P - Purchase | $37.56 | +1,300 | 61,121 | +2% | +$48,824 | ||||||
| D | 2025-07-28 | LUNR | Intuitive Machines, Inc. | Ghaffarian Kamal Seyed | Dir, 10% | S - Sale+OE | $13.49 | -40,254 | 39,734,352 | 0% | -$542,970 | |||||
2025-07-30 | PATH | Uipath, Inc. | Dines Daniel | CEO, COB, 10% | S - Sale | $12.06 | -45,000 | 29,766,961 | 0% | -$542,777 | ||||||
| DM | 2025-07-28 | VC | Visteon Corp | Trecker Kristin | SVP | S - Sale+OE | $113.15 | -2,400 | 9,194 | -21% | -$271,561 | |||||
| M | 2025-07-28 | DMA | Destra Multi-Alternative Fund | Saba Capital Management, L.P. | 10% | P - Purchase | $8.56 | +138,416 | 2,096,470 | +7% | +$1,185,503 | |||||
2025-07-28 | VC | Visteon Corp | Ribeiro Joao Paulo | SVP | S - Sale | $115.10 | -710 | 6,698 | -10% | -$81,717 | ||||||
| D | 2025-07-29 | PPL | Ppl Corp | Bonenberger David J | EVP, COO-Utilities | S - Sale+OE | $35.86 | -2,165 | 50,658 | -4% | -$77,637 | |||||
| D | 2025-07-28 | EFX | Equifax Inc | Begor Mark W | CEO | S - Sale+OE | $241.71 | -48,264 | 246,328 | -16% | -$11,666,013 | |||||
2025-07-28 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $6.57 | -452 | 124,505 | 0% | -$2,970 | ||||||
2025-07-28 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $6.57 | -641 | 164,458 | 0% | -$4,211 | ||||||
2025-07-28 | HCSG | Healthcare Services Group Inc | Shea John Christopher | EVP, Chief Admin. Officer | S - Sale | $13.25 | -21,368 | 32,976 | -39% | -$283,126 | ||||||
2025-07-28 | CELC | Celcuity Inc. | Dalvey David | Dir | S - Sale | $44.07 | -109,325 | 125,000 | -47% | -$4,818,370 | ||||||
2025-07-30 | BXSY | Bexil Investment Trust | Winmill & Co. Inc | See "Explanation of Responses" | P - Purchase | $13.80 | +6,255 | 227,570 | +3% | +$86,319 | ||||||
| D | 2025-07-29 | ARLO | Arlo Technologies, Inc. | McRae Matthew Blake | CEO | S - Sale+OE | $16.56 | -25,380 | 1,461,705 | -2% | -$420,305 | |||||
| D | 2025-07-29 | MCO | Moodys Corp /De/ | West Michael L | Pres, Moody's Investors | S - Sale+OE | $511.10 | -3,704 | 8,209 | -31% | -$1,893,319 | |||||
| M | 2025-07-28 | NTRS | Northern Trust Corp | Fradkin Steven L | Vice COB | S - Sale | $130.69 | -21,680 | 259,418 | -8% | -$2,833,437 | |||||
| D | 2025-07-29 | MCO | Moodys Corp /De/ | Steele Richard G | SVP - GC | S - Sale+OE | $508.83 | -1,457 | 4,999 | -23% | -$741,360 | |||||
2025-07-28 | CRTO | Criteo S.A. | Gleason Brian | CRO, Pres, Retail Media | S - Sale | $22.85 | -2,842 | 152,122 | -2% | -$64,940 | ||||||
| D | 2025-07-28 | DDOG | Datadog, Inc. | Pomel Olivier | CEO | S - Sale+OE | $150.82 | -11,195 | 548,715 | -2% | -$1,688,462 | |||||
2025-07-29 | BSX | Boston Scientific Corp | Fujimori Yoshiaki | Dir | S - Sale | $106.99 | -2,901 | 2,081 | -58% | -$310,378 | ||||||
| D | 2025-07-29 | MCO | Moodys Corp /De/ | Heuland Noemie Clemence | SVP, CFO | S - Sale+OE | $508.24 | -897 | 2,148 | -29% | -$456,109 | |||||
| M | 2025-07-28 | JMSB | John Marshall Bancorp, Inc. | Garcia Michael A | Dir | P - Purchase | $19.17 | +7,023 | 28,210 | +33% | +$134,607 | |||||
2025-07-28 | URGN | Urogen Pharma Ltd. | Smith Jason Drew | GC | S - Sale | $19.14 | -7,522 | 41,492 | -15% | -$143,971 | ||||||
2025-07-28 | URGN | Urogen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | S - Sale | $19.14 | -5,149 | 158,229 | -3% | -$98,552 | ||||||
2025-07-28 | GMGI | Golden Matrix Group, Inc. | Goodman Anthony Brian | CEO, 10% | S - Sale | $1.62 | -50,000 | 16,124,562 | 0% | -$81,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |